Prevention of Postsurgical Chronic Pain in Children and Adolescents (PREVENDOL)
Launched by UNIVERSITY ROVIRA I VIRGILI · Oct 9, 2024
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The PREVENDOL trial is studying how to prevent chronic pain in children and adolescents after they have surgery. Research shows that about 20% of young people who undergo surgery may experience long-lasting pain, which can significantly affect their quality of life. This study aims to identify factors that can help reduce the risk of developing chronic pain, such as managing anxiety and understanding pain better. By focusing on these areas, the trial hopes to create programs that can either prevent this pain from happening or lessen its impact if it does occur.
To be part of this trial, participants need to be between 8 and 18 years old and scheduled for surgery. They must also be able to understand Spanish and provide consent for participation. However, those with certain health issues or who are participating in other clinical trials will not be eligible. If selected, participants can expect to receive support and information to help them manage their pain after surgery. This trial will not only help the participants but could also lead to better treatment options for future children and adolescents facing surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Having to undergo surgery
- • 2. Being between 8 and 18 years old;
- • 3. Having signed the informed consent
- • 4. Having an ASA risk between I and III
- Exclusion Criteria:
- • 1. Not being able to understand Spanish
- • 2. Having a physical and/or cognitive impairment that interferes with understanding the instructions and handling of the application (e.g., moderate to severe intellectual disability, blindness)
- • 3. Participating in another clinical trial
- • 4. Undergoing an urgent surgical intervention
- • 5. Being hospitalized in intensive care due to the need for ventilation or hemodynamic support or other complications
- • 6. Having an ASA risk of IV
- • 7. Not having signed the informed consent
About University Rovira I Virgili
The University Rovira i Virgili (URV) is a prestigious academic institution located in Tarragona, Spain, renowned for its commitment to research and innovation in various fields, including health sciences. With a strong emphasis on interdisciplinary collaboration, URV actively engages in clinical trials aimed at advancing medical knowledge and improving patient care. The university's research initiatives are supported by state-of-the-art facilities and a network of experienced professionals dedicated to conducting high-quality studies that adhere to ethical standards and regulatory guidelines. Through its clinical research endeavors, URV seeks to contribute to the development of new treatments and therapies, ultimately enhancing the health outcomes of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Barcelona, , Spain
Barcelona, , Spain
Tarragona, , Spain
Patients applied
Trial Officials
Elisabet Sánchez-Rodríguez, Dr.
Principal Investigator
University Rovira i Virgili
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported